Coronavirus crisis boosts Sigma earnings

Company says full-year results are in line with guidance

The COVID-19 crisis has given Sigma Healthcare a boost, says CEO Mark Hooper.

Virus crisis boosts Sigma earnings

There had been a significant increase in demand for medicines and FMCG products in the first seven weeks of the current financial year. However, it was “impossible to predict how this will unfold for the remainder of this year”, he said.

“One thing I am certain of, however, is the determination of our team, suppliers and pharmacists to continue to serve the community during this difficult period.”